Decreased glutathione and elevated hair mercury levels are associated with nutritional deficiency-based autism in Oman

Experimental Biology and Medicine

Volumn 239, Issue 6, 2014, Pages 697-706

  Hodgson, Nathaniel W ^a   Waly, Mostafa I ^b,c   Al Farsi, Yahya M ^b,d   Al Sharbati, Marwan M ^b   Al Farsi, Omar ^b   Ali, Amanat ^b   Ouhtit, Allal ^b   Zang, Tianzhu ^a   Zhou, Zhaohui Sunny ^a   Deth, Richard C ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b SULTAN QABOOS UNIVERSITY   (Oman)

^c High Institute of Public Health Egypt   (Egypt)

^d BOSTON UNIVERSITY   (United States)

Author keywords

Cobalamin; epigenetic; folic acid; homocysteine thiolactone; methionine synthase; neurodevelopment

Indexed keywords

CYANOCOBALAMIN; CYSTATHIONINE; CYSTEINE; CYSTINE; FOLIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; HOMOCYSTEINE; HOMOCYSTINE; MERCURY; METHIONINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; THIOL; 5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE;

ARTICLE; AUTISM; CELL METABOLISM; CHEMOLUMINESCENCE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; FEMALE; GENDER; HAIR ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; METHYLATION; NUTRITIONAL DEFICIENCY BASED AUTISM; NUTRITIONAL DISORDER; OXIDATIVE STRESS; PRESCHOOL CHILD; PROTEIN BLOTTING; RATING SCALE; SPEECH DISORDER; SULFURATION; AUTISTIC DISORDER; CLINICAL TRIAL; COMPLICATION; HAIR; MALNUTRITION; METABOLISM; MULTICENTER STUDY; OMAN; RANDOMIZED CONTROLLED TRIAL;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; FEMALE; GLUTATHIONE; HAIR; HUMANS; MALE; MALNUTRITION; MERCURY; OMAN; OXIDATIVE STRESS; S-ADENOSYLMETHIONINE;

EID: 84903388489     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214527900     Document Type: Article

References (84)

1. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.MMWR Surveill Summ. 2012;61:1-19.
2. American Psychiatric Association. Autistic disorder, PDD-NOS, Asperger's disorder, Rett's disorder, and childhood disintegrative disorder. In: Frances A, First M (eds) Diagnostic and statistical manual of mental disorders. 4th ed. (DSM-IV). Washington, DC: American Psychiatric Publishing; 1994.
3. Ashwood P,Anthony A,Torrente F,Wakefield AJ.Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10.J Clin Immunol. 2004;24:664-73.
4. Pardo CA,Vargas DL,Zimmerman AW.Immunity, neuroglia and neuroinflammation in autism.Int Rev Psychiatry. 2005;17:485-95.
5. Vargas DL,Nascimbene C,Krishnan C,Zimmerman AW,Pardo CA.Neuroglial activation and neuroinflammation in the brain of patients with autism.Ann Neurol. 2005;57:67-81.
6. Goines P,Van de Water J.The immune system's role in the biology of autism.Curr Opin Neurol. 2010;23:111-7.
7. Mostafa GA,Al Shehab A,Fouad NR.Frequency of CD4+CD25 high regulatory T cells in the peripheral blood of Egyptian children with autism.J Child Neurol. 2010;25:328-35.
8. Jyonouchi H,Geng L,Streck DL,Toruner GA.Children with autism spectrum disorders (ASD) who exhibit chronic gastrointestinal (GI) symptoms and marked fluctuation of behavioral symptoms exhibit distinct innate immune abnormalities and transcriptional profiles of peripheral blood (PB) monocytes.J Neuroimmunol. 2011;238:73-80.
9. Onore C,Careaga M,Ashwood P.The role of immune dysfunction in the pathophysiology of autism.Brain Behav Immun. 2012;26:383-92.
10. Rossignol DA,Frye RE.A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures.Mol Psychiatry. 2012;17:389-401.
11. Nikolov RN,Bearss KE,Lettinga J,Erickson C,Rodowski M,Aman MG,McCracken JT,McDougle CJ,Tierney E,Vitiello B,Arnold LE,Shah B,Posey DJ,Ritz L,Scahill L.Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.J Autism Dev Disord. 2009;39:405-13.
12. Buie T,Fuchs GJ,Furuta GT,Kooros K,Levy J,Lewis JD,Wershil BK,Winter H.Recommendations for evaluation and treatment of common gastrointestinal problems in children with ASDs.Pediatrics. 2010a;125:S19-29.
13. Buie T,Campbell DB,Fuchs GJ,Furuta GT,Levy J,Vandewater J,Whitaker AH,Atkins D,Bauman ML,Beaudet AL,Carr EG,Gershon MD,Hyman SL,Jirapinyo P,Jyonouchi H,Kooros K,Kushak R,Levitt P,Levy SE,Lewis JD,Murray KF,Natowicz MR,Sabra A,Wershil BK,Weston SC,Zeltzer L,Winter H.Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report.Pediatrics. 2010b;125:S1-18.
14. Williams BL,Hornig M,Buie T,Bauman ML,Cho Paik M,Wick I,Bennett A,Jabado O,Hirschberg DL,Lipkin WI.Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances.PLoS One. 2011;6:e24585-e24585.
15. James SJ,Melnyk S,Jernigan S,Cleves MA,Halsted CH,Wong DH,Cutler P,Bock K,Boris M,Bradstreet JJ,Baker SM,Gaylor DW.Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism.Am J Med Genet B Neuropsychiatr Genet. 2006;141:947-56.
16. Gonzales ML,LaSalle JM.The role of MeCP2 in brain development and neurodevelopmental disorders.Curr Psychiatry Rep. 2010;12:127-34.
17. Mefford HC,Batshaw ML,Hoffman EP.Genomics, intellectual disability, and autism.N Engl J Med. 2012;366:733-43.
18. Morrow EM.Genomic copy number variation in disorders of cognitive development.J Am Acad Child Adolesc Psychiatry. 2010;49:1091-104.
19. Grabrucker AM.Environmental factors in autism.Front Psychiatry. 2012;3:118-118.
20. Landrigan PJ,Lambertini L,Birnbaum LS.A research strategy to discover the environmental causes of autism and neurodevelopmental disabilities.Environ Health Perspect. 2012;120:a258-60.
21. Shelton JF,Hertz-Picciotto I,Pessah IN.Tipping the balance of autism risk: potential mechanisms linking pesticides and autism.Environ Health Perspect. 2012;120:944-51.
22. Deth R,Muratore C,Benzecry J,Power-Charnitsky V-A,Waly M.How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis.Neurotoxicology. 2008;29:190-201.
23. Hochberg Z,Feil R,Constancia M,Fraga M,Junien C,Carel JC,Boileau P,Le Bouc Y,Deal CL,Lillycrop K,Scharfmann R,Sheppard A,Skinner M,Szyf M,Waterland RA,Waxman DJ,Whitelaw E,Ong K,Albertsson-Wikland K.Child health, developmental plasticity, and epigenetic programming.Endocr Rev. 2011;32:159-224.
24. LaSalle JM.A genomic point-of-view on environmental factors influencing the human brain methylome.Epigenetics. 2011;6:862-9.
25. McConkie-Rosell A,Lachiewicz AM,Spiridigliozzi GA,Tarleton J,Schoenwald S,Phelan MC,Goonewardena P,Ding X,Brown WT.Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome.Am J Hum Genet. 1993;53:800-9.
26. Amir RE,Van den Veyver IB,Wan M,Tran CQ,Francke U,Zoghbi HY.Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.Nat Genet. 1999;23:185-8.
27. Thatcher KN,Peddada S,Yasui DH,Lasalle JM.Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples.Hum Mol Genet. 2005;14:785-97.
28. Lertratanangkoon K,Wu CJ,Savaraj N,Thomas ML.Alterations of DNA methylation by glutathione depletion.Cancer Lett. 1997;120:149-56.
29. James SJ,Cutler P,Melnyk S,Jernigan S,Janak L,Gaylor DW,Neubrander JA.Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism.Am J Clin Nutr. 2004;80:1611-17.
30. Chauhan A,Chauhan V.Oxidative stress in autism.Pathophysiology. 2006;13:171-81.
31. James SJ,Melnyk S,Jernigan S,Hubanks A,Rose S,Gaylor DW.Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism.J Autism Dev Disord. 2008;38:1966-75.
32. Pastural E,Ritchie S,Lu Y,Jin W,Kavianpour A,Khine Su-Myat K,Heath D,Wood PL,Fisk M,Goodenowe DB.Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism.Prostaglandins Leukot Essent Fatty Acids. 2009;81:253-64.
33. Al-Gadani Y,El-Ansary A,Attas O,Al-Ayadhi L.Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children.Clin Biochem. 2009;42:1032-40.
34. Geier DA,Kern JK,Garver CR,Adams JB,Audhya T,Nataf R,Geier MR.Biomarkers of environmental toxicity and susceptibility in autism.J Neurol Sci. 2009a;280:101-8.
35. Paşca SP,Dronca E,Kaucsár T,Craciun EC,Endreffy E,Ferencz BK,Iftene F,Benga I,Cornean R,Banerjee R,Dronca M.One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders.J Cell Mol Med. 2009;13:4229-38.
36. Adams JB,Audhya T,McDonough-Means S,Rubin RA,Quig D,Geis E,Gehn E,Loresto M,Mitchell J,Atwood S,Barnhouse S,Lee W.Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity.Nutr Metab (Lond). 2011;8:34-34.
37. Melnyk S,Fuchs GJ,Schulz E,Lopez M,Kahler SG,Fussell JJ,Bellando J,Pavliv O,Rose S,Seidel L,Gaylor DW,James SJ.Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism.J Autism Dev Disord. 2012;42:367-77.
38. Park LK,Friso S,Choi SW.Nutritional influences on epigenetics and age-related disease.Proc Nutr Soc. 2012;71:75-83.
39. Anderson OS,Sant KE,Dolinoy DC.Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation.J Nutr Biochem. 2012;23:853-9.
40. Roy S,Kale A,Dangat K,Sable P,Kulkarni A,Joshi S.Maternal micronutrients (folic acid and vitamin B(12)) and omega 3 fatty acids: implications for neurodevelopmental risk in the rat offspring.Brain Dev. 2012;34:64-71.
41. Al-Farsi YM,Waly MI,Deth RC,Al-Sharbati MM,Al-Shafaee M,Al-Farsi O,Al-Khaduri MM,Gupta I,Ali A,Al-Khalili M,Al-Adawi S,Hodgson NW,Ouhtit A.Low folate and vitamin B12 nourishment is common in Omani children with newly diagnosed autism.Nutrition. 2013;29:537-41.
42. Essa MM,Guillemin GJ,Waly MI,Al-Sharbati MM,Al-Farsi YM,Hakkim FL,Ali A,Al-Shafaee MS.Increased markers of oxidative stress in autistic children of the Sultanate of Oman.Biol Trace Elem Res. 2012;147:25-7.
43. Al-Farsi YM,Al-Sharbati MM,Al-Farsi OA,Al-Shafaee MS,Brooks DR,Waly MI.Brief report: Prevalence of autistic spectrum disorders in the Sultanate of Oman.J Autism Dev Disord. 2011;41:821-5.
44. Jakubowski H,Głowacki R.Chemical biology of homocysteine thiolactone and related metabolites.Adv Clin Chem. 2011;55:81-103.
45. Al-Farsi YM,Waly MI,Al-Sharbati MM,Al-Shafaee MA,Al-Farsi OA,Al-Khaduri MM,Gupta I,Ouhtit A,Al-Adawi S,Al-Said MF,Deth RC.Levels of heavy metals and essential minerals in hair samples of children with autism in Oman: a case-control study.Biol Trace Elem Res. 2013b;151:181-6.
46. Farina M,Avila DS,da Rocha JB,Aschner M.Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury.Neurochem Int. 2013;62:575-94.
47. Carvalho CM,Chew EH,Hashemy SI,Lu J,Holmgren A.Inhibition of the human thioredoxin system. A molecular mechanism of mercury toxicity.J Biol Chem. 2008;283:11913-23.
48. Bernard S,Enayati A,Roger H,Binstock T,Redwood L.The role of mercury in the pathogenesis of autism.Mol Psychiatry. 2002;7:S42-3.
49. Garrecht M,Austin DW.The plausibility of a role for mercury in the etiology of autism: a cellular perspective.Toxicol Environ Chem. 2011;93:1251-1273.
50. Zang T,Dai S,Chen D,Lee BW,Liu S,Karger BL,Zhou ZS.Chemical methods for the detection of protein N-homocysteinylation via selective reactions with aldehydes.Anal Chem. 2009;81:9065-71.
51. Fido A,Al-Saad S.Toxic trace elements in the hair of children with autism.Autism. 2005;9:290-8.
52. Jakubowski H.Aminoacyl thioester chemistry of class II aminoacyl-tRNA synthetases.Biochemistry. 1997;36:11077-85.
53. Paşca SP,Nemeş B,Vlase L,Gagyi CE,Dronca E,Miu AC,Dronca M.High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism.Life Sci. 2006;78:2244-8.
54. Gaita L,Manzi B,Sacco R,Lintas C,Altieri L,Lombardi F,Pawlowski TL,Redman M,Craig DW,Huentelman MJ,Ober-Reynolds S,Brautigam S,Melmed R,Smith CJ,Marsillach J,Camps J,Curatolo P,Persico AM.Decreased serum arylesterase activity in autism spectrum disorders.Psychiatry Res. 2010;180:105-13.
55. Schafer FQ,Buettner GR.Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple.Free Radic Biol Med. 2001;30:1191-212.
56. Clarke DD,Sokoloff LBasic neurochemistry: molecular, cellular and medical aspects. Siegel GJ, ed. Philadelphia, PA: LippincottWilliams &Wilkins; 1999:637-69.
57. Chauhan A,Audhya T,Chauhan V.Brain region-specific glutathione redox imbalance in autism.Neurochem Res. 2012;37:1681-9.
58. Rose S,Melnyk S,Pavliv O,Bai S,Nick TG,Frye RE,James SJ.Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain.Transl Psychiatry. 2012;2:e134-e134.
59. Gu F,Chauhan V,Chauhan A.Impaired synthesis and antioxidant defense of glutathione in the cerebellum of autistic subjects: Alterations in the activities and protein expression of glutathione-related enzymes.Free Radic Biol Med. 2013;65C:488-96.
60. Ludwig ML,Matthews RG.Structure-based perspectives on B12-dependent enzymes.Annu Rev Biochem. 1997;66:269-313.
61. Feinberg AP.Genome-scale approaches to the epigenetics of common human disease.Virchows Arch. 2010;456:13-21.
62. Lv J,Xin Y,Zhou W,Qiu Z.The epigenetic switches for neural development and psychiatric disorders.J Genet Genomics. 2013;40:339-46.
63. Lister R,Mukamel EA,Nery JR,Urich M,Puddifoot CA,Johnson ND,Lucero J,Huang Y,Dwork AJ,Schultz MD,Yu M,Tonti-Filippini J,Heyn H,Hu S,Wu JC,Rao A,Esteller M,He C,Haghighi FG,Sejnowski TJ,Behrens MM,Ecker JR.Global epigenomic reconfiguration during mammalian brain development.Science. 2013;341:1237905-1237905.
64. Mellén M,Ayata P,Dewell S,Kriaucionis S,Heintz N.MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system.Cell. 2012;151:1417-30.
65. Wang T,Pan Q,Lin L,Szulwach KE,Song CX,He C,Wu H,Warren ST,Jin P,Duan R,Li X.Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum.Hum Mol Genet. 2012;21:5500-10.
66. James SJ,Shpyleva S,Melnyk S,Pavliv O,Pogribny IP.Complex epigenetic regulation of engrailed-2 (EN-2) homeobox gene in the autism cerebellum.Transl Psychiatry. 20133:e232-e232.
67. Wong CC, Meaburn EL, Ronald A, Price TS, Jeffries AR, Schalkwyk LC, Plomin R, Mill J. Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Mol Psychiatry 2013. DOI: 10.1038/mp.2013.41. [Epub ahead of print].
68. Muratore CR,Hodgson NW,Trivedi MS,Abdolmaleky HM,Persico AM,Lintas C,De la Monte S,Deth RC.Age-dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autism.PLoS One. 2013;8:e56927-e56927.
69. Glowacki R,Jakubowski H.Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation.J Biol Chem. 2004;279:10864-71.
70. Lakshman MR,Gottipati CS,Narasimhan SJ,Munoz J,Marmillot P,Nylen ES.Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.Metabolism. 2006;55:1201-6.
71. Jakubowski H.The molecular basis of homocysteine thiolactone-mediated vascular disease.Clin Chem Lab Med. 2007;45:1704-16.
72. Aschner M,Onishchenko N,Ceccatelli S.Toxicology of alkylmercury compounds.Met Ions Life Sci. 2010;7:403-34.
73. Carvalho CM,Chew EH,Hashemy SI,Lu J,Holmgren A.Inhibition of the human thioredoxin system. A molecular mechanism of mercury toxicity.J Biol Chem. 2008;283:11913-23.
74. Ralston NV,Ralston CR,Blackwell JL,Raymond LJ.Dietary and tissue selenium in relation to methylmercury toxicity.Neurotoxicology. 2008;29:802-11.
75. Steinbrenner H,Sies H.Selenium homeostasis and antioxidant selenoproteins in brain: Implications for disorders in the central nervous system.Arch Biochem Biophys. 2013;536:152-7.
76. Park JD,Zheng W.Human exposure and health effects of inorganic and elemental mercury.J Prev Med Public Health. 2012;45:344-52.
77. Bose R,Onishchenko N,Edoff K,Janson Lang AM,Ceccatelli S.Inherited effects of low-dose exposure to methylmercury in neural stem cells.Toxicol Sci. 2012;130:383-90.
78. Goodrich JM,Basu N,Franzblau A,Dolinoy DC.Mercury biomarkers and DNA methylation among Michigan dental professionals.Environ Mol Mutagen. 2013;54:195-203.
79. Hill KE,Zhou J,McMahan WJ,Motley AK,Atkins JF,Gesteland RF,Burk RF.Deletion of selenoprotein P alters distribution of selenium in the mouse.J Biol Chem. 2003;278:13640-6.
80. Holmes AS,Blaxill MF,Haley BE.Reduced levels of mercury in first baby haircuts of autistic children.Int J Toxicol. 2003;22:277-85.
81. Albizzati A,Morè L,Di Candia D,Saccani M,Lenti C.Normal concentrations of heavy metals in autistic spectrum disorders.Minerva Pediatr. 2012;64:27-31.
82. Al-Ayadhi LY.Heavy metals and trace elements in hair samples of autistic children in central Saudi Arabia.Neurosciences (Riyadh). 2005;10:213-18.
83. Blaurock-Busch E,Amin OR,Dessoki HH,Rabah T.Toxic metals and essential elements in hair and severity of symptoms among children with autism.Maedica (Buchar). 2012;7:38-48.
84. Yasuda H,Yasuda Y,Tsutsui T.Estimation of autistic children by metallomics analysis.Sci Rep. 2013;3:1199-1199.